Application
DHTKD1 Antibody (Center) western blot analysis in mouse liver tissue lysates (35ug/lane).This demonstrates the DHTKD1 antibody detected the DHTKD1 protein (arrow).| Product Name | DHTKD1 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | DHTKD1; KIAA1630; Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial; Dehydrogenase E1 and transketolase domain-containing protein 1 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | KIAA1630 |
|---|---|
| Alternative Names | DHTKD1 KIAA1630 Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 mitochondrial Dehydrogenase E1 and transketolase domain-containing protein 1 |
| Molecular Weight(MW) | 103077 Da |
| Function | The 2-oxoglutarate dehydrogenase complex catalyzes the overall conversion of 2-oxoglutarate to succinyl-CoA and CO(2). It contains multiple copies of three enzymatic components: 2- oxoglutarate dehydrogenase (E1), dihydrolipoamide succinyltransferase (E2) and lipoamide dehydrogenase (E3) (By similarity) |
| Tissue Specificity | This DHTKD1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 395-425 amino acids from the Central region of human DHTKD1. |
| Cellular Localization | Mitochondrion (Potential). |
| Entrez Gene | 55526 |
|---|---|
| Nucleotide Accession | NP_061176.3 |
Application
DHTKD1 Antibody (Center) western blot analysis in mouse liver tissue lysates (35ug/lane).This demonstrates the DHTKD1 antibody detected the DHTKD1 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
